GLP-1R Agonists in the Treatment of Diabetes Mellitus: Reducing Serious Comorbidities
W. Marshall Fettig Background: Type 2 Diabetes Mellitus (T2DM) is a major health problem worldwide, characterized by persistent hyperglycemia, and associated with both long and short-term complications. T2DM affects approximately 374 million adults aged 20-79 worldwide,1 and its impact on the US economy was estimated at $327 billion in 2017.2…